CN103169570A - Hemostasis bandaid and preparation method thereof - Google Patents

Hemostasis bandaid and preparation method thereof Download PDF

Info

Publication number
CN103169570A
CN103169570A CN2013100709827A CN201310070982A CN103169570A CN 103169570 A CN103169570 A CN 103169570A CN 2013100709827 A CN2013100709827 A CN 2013100709827A CN 201310070982 A CN201310070982 A CN 201310070982A CN 103169570 A CN103169570 A CN 103169570A
Authority
CN
China
Prior art keywords
alginic acid
bandaid
woven fabrics
binder
acid fibre
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013100709827A
Other languages
Chinese (zh)
Inventor
周立新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU EMY MEDICAL SUPPLIES CO Ltd
Original Assignee
SUZHOU EMY MEDICAL SUPPLIES CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU EMY MEDICAL SUPPLIES CO Ltd filed Critical SUZHOU EMY MEDICAL SUPPLIES CO Ltd
Priority to CN2013100709827A priority Critical patent/CN103169570A/en
Publication of CN103169570A publication Critical patent/CN103169570A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

The invention provides a hemostasis bandaid and a preparation method of the hemostasis bandaid, and belongs to the field of surgical dressing. The hemostasis bandaid comprises a bandaid body and a wound treating pad. The wound treating pad is combined on one side surface of one end of the length direction of the bandaid body, and a transition distance is reserved between the wound treating pad and the end portion of the end with the wound treating pad. The hemostasis bandaid is characterized in that the hemostasis bandaid is formed by alginic acid fiber non-woven fabrics, an anti-adhesion thin film and a polyurethane breathable thin film, the anti-adhesion thin film is combined on one side, facing the wound of a patient, of the alginic acid fiber non-woven fabrics in a using state. The polyurethane breathable thin film is combined on the side, facing the bandaid body, of the alginic acid fiber non-woven fabrics, and the bandaid body is medical absorbent gauze. The hemostasis bandaid not only has good effects of liquid imbibition and seepage resistance, but also has excellent effects of hemostasis, antibiosis, healing promotion and pain relieving to the wound, can avoid blindness, avoid waste and reduce treatment cost of the patient, cannot cause adhesion to the wound, and can meet requirements of expanding production of industrialization.

Description

First-aid hemostatic binder and preparation method thereof
Technical field
the invention belongs to the medical dressing technical field, be specifically related to a kind of first-aid hemostatic binder, and relate to the preparation method of this first-aid hemostatic binder.
Background technology
at present in medical treatment, generally use cheap gauze as the first-aid hemostatic binder, although this binder can meet the wrapping requirement to wound, but objectively there is following shortcoming: the one, due to the imbibition antiseep weak effect of gauze, therefore be prone to blood stains and medicinal liquid osmosis phenomenon, both diminished sight, easily produce and pollute again, for example dirty and dress ornament; The 2nd, as the aforementioned antiseep of the imbibition due to gauze weak effect, so the medical worker when disposing usually with peaceful many not few modes some layers that are wrapped, thereby cause the material consumption amount large, cause unnecessary waste, and the treatment cost that the patient bears increases; The 3rd, easily with wound, stick together, although make in healing but still the wound in fragile state is subject to secondary damage (tearing) when withdrawing binder; The 4th, because gauze self does not have the function of antibiotic to wound, short and pain relieving and so on, only can play being positioned at the effect of applying ointment or plaster and fixing and being hedged off from the outer world at wound place.
for above-mentioned prior art, be necessary to be improved, for this reason, the applicant has done useful design, and technical scheme described below produces under this background.
Summary of the invention
top priority of the present invention is to provide a kind of and contributes to embody good imbibition antiseep effect and use and avoid producing pollution because leaking outside, be conducive to reduce the winding number of plies of wound is used and saved consumption and alleviate patient's expense expenditure, be of value to and avoid preventing to wound is produced secondary damage and has the hemostasis being convenient to embody to wound, antibiotic, short and pain-relieving functions to use the first-aid hemostatic binder that ensures desirable therapeutic effect with the wound adhesion.
another task of the present invention is to provide a kind of preparation method of first-aid hemostatic binder, and the method not only processing step briefly can meet the industrial amplification production requirement, and can ensure comprehensive embodiment of the described technique effect of first-aid hemostatic binder.
for embodiment completes top priority of the present invention, technical scheme provided by the invention is: a kind of first-aid hemostatic binder, comprise a binder body and a Wound healing and bone regeneration pad, the Wound healing and bone regeneration pad is combined in the side surface of an end of the length direction of binder body, and maintain transition distance with the end of this end, be characterised in that: described treatment pad is by the alginic acid fibre non-woven fabrics, anti thin film and polyurethane breathable films form, the anti thin film is combined in alginic acid fibre non-woven fabrics side towards patient's wound under using state, the polyurethane breathable films is combined in the side of alginic acid fibre non-woven fabrics towards described binder body, described binder body is medical absorbent cotton/gauze.
in a specific embodiment of the present invention, described transition distance is 5-10 ㎝.
in another specific embodiment of the present invention, the length of described binder body is 250-360 ㎝, and width is 5-15 ㎝, and the width of described Wound healing and bone regeneration pad equates with the width of described binder body.
in another specific embodiment of the present invention, the number of warp thread that forms the yarn of described medical absorbent cotton/gauze is different from the number of weft yarn, and is unequal at the radical of the warp thread of going up per square inch and the radical of weft yarn.
in another specific embodiment of the present invention, the number of described warp thread is 21S, and the number of described weft yarn is 32S, is 28 at the radical of the described warp thread of going up per square inch, and is 20 at the radical of the weft yarn of going up per square inch.
also have a specific embodiment of the present invention, described alginic acid fibre non-woven fabrics is to be the alginic acid fibre non-weaving cloth that grammes per square metre that the needing machine acupuncture of alginic acid fibre in nonwovens process that 4-8 ㎝ and fiber number are 2-3.5dtex obtains is 120-200g/ ㎡ by length; The grammes per square metre of described anti thin film is 15-20g/ ㎡; The grammes per square metre of described polyurethane breathable films is 2-5g/ ㎡.
for embodiment completes another task of the present invention, technical scheme provided by the invention is: a kind of preparation method of first-aid hemostatic binder comprises the following steps:
a) prepare the Wound healing and bone regeneration pad, first by thermal composite machine, the anti film thermal is compound in to a side of alginic acid fibre non-woven fabrics, and polyurethane breathable films heat is compound in to the opposite side of alginic acid fibre non-woven fabrics, then cut, obtain the Wound healing and bone regeneration pad;
b) prepare finished product, will be by steps A by presses) the Wound healing and bone regeneration pad flatiron that equates with the width of binder body of the width obtained is incorporated into a side surface of an end of binder body, after rolling and packing, obtains the first-aid hemostatic binder.
more of the present invention and in specific embodiment, steps A) the hot combined temp that the anti film thermal described in is compound in a side of described alginic acid fibre non-woven fabrics is 110-120 ℃; The hot combined temp that described polyurethane breathable films heat is compound in the opposite side of alginic acid fibre is 105-115 ℃.
the temperature of the flatiron in of the present invention and then specific embodiment, step B) is 115-125 ℃.
technical scheme provided by the invention is owing to being combined with the Wound healing and bone regeneration pad consisted of alginic acid fibre non-woven fabrics, anti thin film and polyurethane ventilated membrane on the binder body, thereby not only there is good imbibition antiseepage and divulge effect, and there is the excellent effect such as hemostasis, antibiotic, short and pain relieving to wound; Owing to combining the Wound healing and bone regeneration pad on the binder body, thereby the binder body can be designed to rational length, not only can avoid blindness, and can avoid waste and alleviate patient's medical expense expenditure; Because the anti thin film has excellent preventing adhesiving effect, thereby can not cause adhesion to wound; Because the preparation method technical process provided is brief, thereby can meet the industrial amplification production requirement.
The accompanying drawing explanation
fig. 1 is the embodiments of the invention structure chart.
The specific embodiment
embodiment 1:
the step of tourniquet bandage for preparing structure shown in Fig. 1 is as follows:
a) prepare the Wound healing and bone regeneration pad, the anti thin film 22 that is first 15g/ ㎡ by thermal composite machine by grammes per square metre be take and heated compound mode and be compound to alginic acid fibre non-woven fabrics 21 that grammes per square metre the is 160g side surface towards patient's wound under using state at the heating combined temp under 110 ℃, and be 2g/ ㎡ polyurethane breathable films 23 to heat compound mode and be compound to the opposite side of alginic acid fibre non-woven fabrics 21 at the temperature of 105 ℃ by grammes per square metre, cut into by guillotine the square that the length of side is 10 ㎝ again, obtain Wound healing and bone regeneration pad 2, it is the mesh isolating membrane that CM type mesh isolating membrane or employing U.S. moral star company sell in China that anti thin film described in this step is preferably used the trade mark of being sold in Chinese market before the application proposes by brightness company of Britain Xerox, the alginic acid fibre non-weaving cloth that described alginic acid fibre non-woven fabrics 21 is is 160g/ ㎡ by the length grammes per square metre that to be 4-8 ㎝ and the fiber number alginic acid fibre that is 2-3.5dtex obtain through nonwovens process and needing machine acupuncture,
b) be prepared into cloth, will be by steps A by presses) Wound healing and bone regeneration pad 2 flatirons that obtain are incorporated into a side surface of an end of binder body 1, and this Wound healing and bone regeneration pad 2 maintains transition distance with the end of an end of binder body 1, this transition distance is 5 ㎝, that is to say that Wound healing and bone regeneration pad 2 is positioned at apart from the position of end end 5 ㎝ of binder body 1, aforementioned ironing temperature in this step is 120 ℃, after rolling, pack, obtain the first-aid hemostatic binder of structure as shown in Figure 1, the length of described binder body 1 is 250 ㎝, width is 10 ㎝, binder body 1 is medical absorbent cotton/gauze, and the number of warp thread that forms the yarn of this medical absorbent cotton/gauze is that 21S(21 props up), and being 32S(32, props up the number of weft yarn), radical at the warp thread of going up per square inch is 28, and the radical of weft yarn is 20.
embodiment 2:
only by steps A) in the grammes per square metre of anti thin film 22 change 20g/ ㎡ into, change anti thin film 22 and the heating combined temp of alginic acid fibre non-woven fabrics 21 into 115 ℃, the grammes per square metre of alginic acid fibre non-woven fabrics 21 changes 200g/ ㎡ into, and alginic acid fibre non-woven fabrics 21 adopt by the safe medical dressing of Changshu, Jiangsu Province, China citizen Co., Ltd, produced and before the application proposes the trade mark in market sale be MT-II-A biological fiber non-woven fabrics, change polyurethane breathable films 23 and the heating combined temp of alginic acid fibre non-woven fabrics 21 into 115 ℃, the grammes per square metre of polyurethane breathable films 23 changes 3g/ ㎡ into, the length of side of the Wound healing and bone regeneration pad 2 after cutting changes 15 ㎝ into, by step B) in ironing temperature change 125 ℃ into, change transition distance into 10 ㎝, change the length of binder body 1 into 360 ㎝, width changes 15 ㎝ into, all the other are all with the description to embodiment 1.
embodiment 3:
only by steps A) in the grammes per square metre of anti thin film 22 change 17g/ ㎡ into, change anti thin film 22 and the heating combined temp of alginic acid fibre non-woven fabrics 21 into 120 ℃, the grammes per square metre of alginic acid fibre non-woven fabrics 21 changes 120g/ ㎡ into, and change polyurethane breathable films 23 and the heating combined temp of alginic acid fibre non-woven fabrics 21 into 110 ℃, the grammes per square metre of polyurethane breathable films 23 changes 5g/ ㎡ into, and the length of side of the Wound healing and bone regeneration pad 2 after cutting changes 5 ㎝ into; By step B) in ironing temperature change 125 ℃ into, change transition distance into 8 ㎝, change the length of binder body 1 into 305 ㎝, and change width into 5 ㎝, all the other are all with the description to embodiment 1.

Claims (9)

1. a kind of first-aid hemostatic binder, comprise a binder body (1) and a Wound healing and bone regeneration pad (2), Wound healing and bone regeneration pad (2) is combined in the side surface of an end of the length direction of binder body (1), and maintain transition distance with the end of this end, it is characterized in that: described treatment pad (2) is by alginic acid fibre non-woven fabrics (21), anti thin film (22) and polyurethane breathable films (23) form, anti thin film (22) is combined in alginic acid fibre non-woven fabrics (21) side towards patient's wound under using state, polyurethane breathable films (33) is combined in the side of alginic acid fibre non-woven fabrics (21) towards described binder body (1), described binder body (1) is medical absorbent cotton/gauze.
2. first-aid hemostatic binder according to claim 1, is characterized in that described transition distance is 5-10 ㎝.
3. first-aid hemostatic binder according to claim 1, the length that it is characterized in that described binder body (1) is 250-360 ㎝, and width is 5-15 ㎝, and the width of described Wound healing and bone regeneration pad (2) equates with the width of described binder body (1).
4. first-aid hemostatic binder according to claim 1, the number of warp thread that it is characterized in that forming the yarn of described medical absorbent cotton/gauze is different from the number of weft yarn, and is unequal at the radical of the warp thread of going up per square inch and the radical of weft yarn.
5. first-aid hemostatic binder according to claim 4, the number that it is characterized in that described warp thread is 21S, the number of described weft yarn is 32S, is 28 at the radical of the described warp thread of going up per square inch, and is 20 at the radical of the weft yarn of going up per square inch.
6. first-aid hemostatic binder according to claim 1, is characterized in that described alginic acid fibre non-woven fabrics (21) is is the alginic acid fibre non-weaving cloth that grammes per square metre that the needing machine acupuncture of alginic acid fibre in nonwovens process that 4-8 ㎝ and fiber number are 2-3.5dtex obtains is 120-200g/ ㎡ by length; The grammes per square metre of described anti thin film (22) is 15-20g/ ㎡; The grammes per square metre of described polyurethane breathable films (23) is 2-5g/ ㎡.
7. a kind of preparation method of first-aid hemostatic binder as claimed in claim 1 is characterized in that comprising the following steps:
a) prepare the Wound healing and bone regeneration pad, first by thermal composite machine, anti thin film (22) heat is compound in to a side of alginic acid fibre non-woven fabrics (21), and polyurethane breathable films (23) heat is compound in to the opposite side of alginic acid fibre non-woven fabrics (21), then cut, obtained Wound healing and bone regeneration pad (2);
b) prepare finished product, will be by steps A by presses) Wound healing and bone regeneration pad (2) flatiron that equates with the width of binder body (1) of the width obtained is incorporated into a side surface of an end of binder body (1), after rolling and packing, obtains the first-aid hemostatic binder.
8. the preparation method of first-aid hemostatic binder according to claim 7, is characterized in that steps A) described in anti thin film (22) the heat hot combined temp that is compound in a side of described alginic acid fibre non-woven fabrics (21) be 110-120 ℃; The hot combined temp that described polyurethane breathable films (23) heat is compound in the opposite side of alginic acid fibre (21) is 105-115 ℃.
9. the preparation method of first-aid hemostatic binder according to claim 7, is characterized in that step B) described in the temperature of flatiron be 115-125 ℃.
CN2013100709827A 2013-03-06 2013-03-06 Hemostasis bandaid and preparation method thereof Pending CN103169570A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013100709827A CN103169570A (en) 2013-03-06 2013-03-06 Hemostasis bandaid and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013100709827A CN103169570A (en) 2013-03-06 2013-03-06 Hemostasis bandaid and preparation method thereof

Publications (1)

Publication Number Publication Date
CN103169570A true CN103169570A (en) 2013-06-26

Family

ID=48630069

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013100709827A Pending CN103169570A (en) 2013-03-06 2013-03-06 Hemostasis bandaid and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103169570A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103768650A (en) * 2014-01-26 2014-05-07 深圳市博立生物材料有限公司 Wound regenerating and repairing bandage and manufacture method thereof
CN104224446A (en) * 2014-09-03 2014-12-24 常州好安生物科技有限公司 Alginate adhesive bandage and manufacturing method of alginate adhesive bandage
CN104695128A (en) * 2013-12-04 2015-06-10 东纶科技实业有限公司 Alginate fiber non-woven material and preparing method thereof
CN105764432A (en) * 2013-11-15 2016-07-13 基麦泰克有限责任公司 Tourniquet
CN108950820A (en) * 2018-07-05 2018-12-07 嘉兴市盛翔织造有限公司 A kind of high-elastic colored fabric and its processing method for medical bandage
CN109077850A (en) * 2018-08-03 2018-12-25 安吉正达医疗科技有限公司 A kind of low Engorged quantity hemostatic gauze of first aid
CN112618160A (en) * 2021-01-06 2021-04-09 扬州市凯瑞特医疗用品有限公司 Medical core that applies

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2046383U (en) * 1989-05-06 1989-10-25 刘崇敬 Bandage with chinese medicine-hemostatic
CN201085737Y (en) * 2007-09-14 2008-07-16 中国人民解放军军事医学科学院卫生装备研究所 Three-protective dressing for first aid
CN201930137U (en) * 2011-01-26 2011-08-17 稳健实业(深圳)有限公司 Medical dressing
CN102350005A (en) * 2011-10-25 2012-02-15 中国纺织科学研究院 Medical moist composite dressing and preparation method thereof
CN203089550U (en) * 2013-03-06 2013-07-31 苏州艾美医疗用品有限公司 Blood-stopping bandaid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2046383U (en) * 1989-05-06 1989-10-25 刘崇敬 Bandage with chinese medicine-hemostatic
CN201085737Y (en) * 2007-09-14 2008-07-16 中国人民解放军军事医学科学院卫生装备研究所 Three-protective dressing for first aid
CN201930137U (en) * 2011-01-26 2011-08-17 稳健实业(深圳)有限公司 Medical dressing
CN102350005A (en) * 2011-10-25 2012-02-15 中国纺织科学研究院 Medical moist composite dressing and preparation method thereof
CN203089550U (en) * 2013-03-06 2013-07-31 苏州艾美医疗用品有限公司 Blood-stopping bandaid

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105764432A (en) * 2013-11-15 2016-07-13 基麦泰克有限责任公司 Tourniquet
CN104695128A (en) * 2013-12-04 2015-06-10 东纶科技实业有限公司 Alginate fiber non-woven material and preparing method thereof
CN103768650A (en) * 2014-01-26 2014-05-07 深圳市博立生物材料有限公司 Wound regenerating and repairing bandage and manufacture method thereof
CN104224446A (en) * 2014-09-03 2014-12-24 常州好安生物科技有限公司 Alginate adhesive bandage and manufacturing method of alginate adhesive bandage
CN108950820A (en) * 2018-07-05 2018-12-07 嘉兴市盛翔织造有限公司 A kind of high-elastic colored fabric and its processing method for medical bandage
CN109077850A (en) * 2018-08-03 2018-12-25 安吉正达医疗科技有限公司 A kind of low Engorged quantity hemostatic gauze of first aid
CN109077850B (en) * 2018-08-03 2024-05-24 新疆国投妙仁医疗用品有限公司 Hemostatic gauze with low blood sucking amount for emergency treatment
CN112618160A (en) * 2021-01-06 2021-04-09 扬州市凯瑞特医疗用品有限公司 Medical core that applies

Similar Documents

Publication Publication Date Title
CN103169570A (en) Hemostasis bandaid and preparation method thereof
CA2895677C (en) A combined compression and absorption dressing/bandage
JP2008544794A (en) Wound dressing material
CN103110477B (en) Manufacturing method of composite medical non-woven fabric absorbent pads
CN203089550U (en) Blood-stopping bandaid
CN106178069A (en) A kind of first aid bleeding-stopping dressing and preparation method thereof
CN204147170U (en) A kind of novel Wound dressings
CN105521519B (en) A kind of deposited core of alginates
CN209596034U (en) A heat-shrinkable absorbent gauze
CN103266422A (en) Method for preparing medical bamboo fiber surgical dressing
CN202605128U (en) An antibacterial dressing
CN202740226U (en) Elastic polyurethane non-woven adhesive bandage plaster
CN203226950U (en) Hydrogel medical dressing
CN208319412U (en) Self-adhering-type surgical incision dressing
CN105287105A (en) Coating-free anti-adhesion absorbent pad and production process thereof
CN209564301U (en) A kind of anti-microbial elastomeric bandage
CN213218231U (en) Anti-staining adhesive bandage for hemodialysis
CN105030418A (en) Absorbent pad for bandages
CN106510950A (en) Dressing
CN113041028A (en) Waterproof high-breathability non-woven fabric and manufacturing method thereof
CN201743978U (en) Waterproof, astringent double-effect wound fast healing stick
CN205667606U (en) A kind of medical adhesive tape with fine air permeability
CN204092092U (en) Novel hemostatic dressing plaster
CN209426323U (en) A kind of absorbent cotton spunlaced nonwoven fabric for antibacterial medical dressing
CN219579223U (en) Comfortable breathable antibacterial cotton

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130626